Slotting right into 2020’s frothy stock market, DoorDash (DASH) made its public debut on Wednesday, with shares soaring by 86% in its maiden session. The food...
US stocks are struggling for direction as investor skepticism over a holiday stimulus deal grows, jobless claims are starting to trend higher, and as the red-hot...
Leaving aside the day-to-day fluctuations, markets are on an upswing. The NASDAQ, the popular tech-heavy index, is within 2% of its all-time high, and the S&P...
Leaving aside the day-to-day fluctuations, markets are on an upswing. The NASDAQ, the popular tech-heavy index, is within 2% of its all-time high, and the S&P...
Investing is all about profits, and part of generating profits is knowing when to start the game. The old adage says to buy low and sell...
Biogen has filed a new drug application to Japan’s regulator for the approval of aducanumab, its investigational treatment for Alzheimer’s disease, which it is developing together...
US equities fall as stimulus talks stall Despite the Door Dash IPO euphoria overnight, New York’s major indexes all closed lower, with the Nasdaq underperforming as...
While several businesses continue to succumb to an unprecedented pandemic, certain semiconductor companies are seeing strong growth driven by demand in end markets like cloud computing,...
Shares of Starbucks rose over 3.5% on Wednesday’s extended trading after the multinational coffeehouse chain operator raised its long-term earnings forecast. Moreover, the company reiterated its...
Shares of Immutep exploded 63% in Wednesday’s extended trading session after the company reported encouraging first overall survival (OS) data from its ongoing Phase IIb AIPAC...
2020 has been some journey for Inovio Pharmaceuticals (INO). For this formerly little-known biotech, the narrative has swung from outlandishly exuberant to hopelessly gloomy, all due...
The markets have been on a tear of late despite the headwinds presented by the novel coronavirus pandemic. The question is how long this will last?...
The big picture is looking up as we head toward the Christmas and New Year holiday season. Despite continued pressure from the coronavirus crisis, markets are...
Peter Thiel, the billionaire libertarian who quietly backed away in 2020 from his once-ardent support of President Donald Trump, is no stranger to government contracts. His...
Pfizer Inc. and BioNTech’s mRNA vaccine candidate, BNT162b2, against COVID-19, was found to be safe and effective, according to the latest analysis by the US Food...
Roche has partnered with Moderna Inc. to use its anti-SARS-CoV-2 S antibody test in mRNA-1273 vaccine research trials. According to Roche (GB:0QOK), the Elecsys test facilitates...
Futures Hit New All Time High As Manic Melt Up Won't Stop Tyler Durden Wed, 12/09/2020 - 08:04 The market meltup just won't let up, with...
At this week’s annual meeting of the American Society of Hematology, Bluebird Bio announced favorable updates related to its gene therapy for sickle cell disease (SCD)....
TJX Companies declared a quarterly dividend of $0.26 per share, reflecting a 13% increase from the previous dividend paid in March 2020. The off-price retailer had...
Used car demand has notably increased over recent months. Factors like an uncertain economy, the preference for an owned vehicle given the apprehension to use public...
Last week, the UK became the first western country to begin the rollout of a COVID-19 vaccine. The Medicines and Healthcare products Regulatory Agency (MHRA) -...
At the end of 2018, Canada fully legalized cannabis, nationwide, for both medical and recreational use. With the incoming Biden Administration, the US is expected to...
Every week, Benzinga conducts a sentiment survey to find out what traders are most excited about, interested in or thinking about as they manage and build...
On Wall Street, it’s out with tech and mega-caps and in with small-caps, cyclicals and value. Investors have been rotating away from the big names that...
Future study books will linger long and hard on the tumultuous events of 2020. Among the mountains of interesting information, Moderna (MRNA) is very likely to...
The timing of the Airbnb IPO seems near-perfect with respect to the approval and application of Covid vaccines. Learn more.
Futures Slide On Lack Of Stimulus Deal Progress, Vaccine Disappointment Tyler Durden Tue, 12/08/2020 - 08:02 Global markets dropped for a second day and US equity...
China stocks dip on geo-politics Mixed is an apt description for both the overnight US session and today’s Asian session for the stock markets. Overnight, the...
AbCellera Biologics has been in the spotlight since coming up with Eli Lilly’s COVID-19 antibody drug bamlanivimab, and The post AI drug discovery biotech AbCellera eyes...
The pandemic has had a very mixed impact on companies in the entertainment industry. On the one hand, theater chains and theme parks booked huge losses...